UK markets open in 4 hours 42 minutes

Reneo Pharmaceuticals, Inc. (RPHM)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.70000.0000 (0.00%)
At close: 04:00PM EDT
1.7000 0.00 (0.00%)
After hours: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-70,707
-77,388
-51,955
-39,770
-19,465
-
Depreciation & amortisation
145
170
88
50
37
-
Stock-based compensation
5,033
5,112
4,320
3,891
393
-
Change in working capital
-5,854
12,218
959
-2,800
514
-
Accounts payable
-
-
-
1,780
1,486
1,034
Other working capital
-75,697
-63,903
-47,708
-38,181
-18,560
-
Other non-cash items
-15
333
26
-
-
673
Net cash provided by operating activities
-75,648
-63,682
-47,362
-37,983
-18,536
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-221
-346
-198
-24
-
Purchases of investments
-248,179
-231,257
-101,596
-31,406
0
-
Sales/maturities of investments
254,000
242,000
44,100
8,228
7,400
-
Net cash used for investing activities
5,772
10,522
-57,842
-23,376
7,376
-
Cash flows from financing activities
Common stock issued
63,529
64,538
193
84,612
0
-
Common stock repurchased
-
-4,403
0
-
-
-
Other financing activities
-
-
193
-
-
-
Net cash used provided by (used for) financing activities
59,856
60,865
471
132,406
47,272
-
Net change in cash
-10,020
7,705
-104,733
71,047
36,112
-
Cash at beginning of period
30,395
19,927
124,660
53,613
17,501
-
Cash at end of period
20,375
27,632
19,927
124,660
53,613
-
Free cash flow
Operating cash flow
-75,648
-63,682
-47,362
-37,983
-18,536
-
Capital expenditure
-
-221
-346
-198
-24
-
Free cash flow
-75,697
-63,903
-47,708
-38,181
-18,560
-